Rentracks CO.,LTD. Logo

Rentracks CO.,LTD.

A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.

6045 | T

Overview

Corporate Details

ISIN(s):
JP3981850005
LEI:
Country:
Japan
Address:
江戸川区西葛西五丁目2番3号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Rentracks CO.,LTD. is a digital advertising company focused on maximizing client profitability through internet-based solutions. The company's core business is its Affiliate Service Provider (ASP) platform, which operates a complete pay-per-performance advertising network. This service connects advertisers with publishers, mediating ad distribution and managing performance-based commissions. A key feature is its 'Closed ASP' model, which cultivates an exclusive network of high-performing affiliates ('super affiliates') to enhance campaign effectiveness. In addition to its affiliate network, Rentracks offers comprehensive Web Consulting services, including SEO, SEM, website production, and advertising agency functions. The company also engages in an Internet Media business, developing and operating its own portfolio of websites.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:42
Registration Form
確認書
Japanese 8.2 KB
2025-11-14 07:40
Interim Report
半期報告書-第21期(2025/04/01-2026/03/31)
Japanese 172.8 KB
2025-06-30 07:56
Post-Annual General Meeting Information
臨時報告書
Japanese 20.8 KB
2025-06-24 08:30
Registration Form
確認書
Japanese 8.1 KB
2025-06-24 08:30
Governance Information
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 22.2 KB
2025-06-24 08:30
Annual Report
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 1008.4 KB
2025-05-30 08:47
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-11 09:40
Major Shareholding Notification
大量保有報告書
Japanese 35.5 KB
2024-11-14 07:12
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-14 07:11
Interim Report
半期報告書-第20期(2024/04/01-2025/03/31)
Japanese 173.8 KB
2024-06-28 08:04
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2024-06-27 08:48
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 08:47
Governance Information
内部統制報告書-第19期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-27 08:46
Annual Report
有価証券報告書-第19期(2023/04/01-2024/03/31)
Japanese 1022.9 KB
2024-02-13 07:12
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Rentracks CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Rentracks CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Rentracks CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.